Targeted gene delivery to CD117‐expressing cells in vivo with lentiviral vectors co‐displaying stem cell factor and a fusogenic molecule
Authors:
- 17 April 2009
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 104 (1) , 206-215
Abstract
The development of a lentiviral system to deliver genes to specific cell types could improve the safety and the efficacy of gene delivery. Previously, we have developed an efficient method to target lentivectors to specific cells via an antibody–antigen interaction in vitro and in vivo. We report herein a targeted lentivector that harnesses the natural ligand–receptor recognition mechanism for targeted modification of c‐KIT receptor‐expressing cells. For targeting, we incorporate membrane‐bound human stem cell factor (hSCF), and for fusion, a Sindbis virus‐derived fusogenic molecule (FM) onto the lentiviral surface. These engineered vectors can recognize cells expressing surface CD117, resulting in efficient targeted transduction of cells in an SCF‐receptor dependent manner in vitro, and in vivo in xenografted mouse models. This study expands the ability of targeting lentivectors beyond antibody targets to include cell‐specific surface receptors. Development of a high titer lentivector to receptor‐specific cells is an attractive approach to restrict gene expression and could potentially ensure therapeutic effects in the desired cells while limiting side effects caused by gene expression in non‐target cells. Biotechnol. Bioeng. 2009; 104: 206–215Keywords
This publication has 36 references indexed in Scilit:
- Visualization of targeted transduction by engineered lentiviral vectorsGene Therapy, 2008
- Gamma‐retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen‐specific targetingBiotechnology and Bioengineering, 2008
- General Strategy for Decoration of Enveloped Viruses with Functionally Active Lipid-Modified CytokinesJournal of Virology, 2007
- Library selection and directed evolution approaches to engineering targeted viral vectorsBiotechnology and Bioengineering, 2007
- Targeting lentiviral vectors to specific cell types in vivoProceedings of the National Academy of Sciences, 2006
- Cell Type–Specific Targeting with Sindbis Pseudotyped Lentiviral Vectors Displaying Anti-CCR5 Single-Chain AntibodiesHuman Gene Therapy, 2005
- Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cellsMolecular Therapy, 2004
- A soluble CAR‐SCF fusion protein improves adenoviral vector‐mediated gene transferto c‐Kit‐positive hematopoietic cellsThe Journal of Gene Medicine, 2003
- Selective Targeting and Inducible Destruction of Human Cancer Cells by Retroviruses with Envelope Proteins Bearing Short Peptide LigandsJournal of Virology, 2002
- Efficient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem CellsJournal of Virology, 2001